Effects of chemokine receptor CCR7 in the pathophysiology and clinical features of the immuno-inflammatory response in primary pterygium
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110086 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Ting Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Ophthalmology, The Third Affili…. Hauptthemen laut MEDLINE: Pterygium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Sun Yat-sen University.
Abstract (Originalsprache)
OBJECTIVE: Chemokine receptor 7 (CCR7) has been considered a critical biomarker in inflammation and the immune response; however, little is known about CCR7 in pterygia. This study aimed to investigate whether CCR7 participates in the pathogenesis of primary pterygia and how CCR7 affects the progression of pterygia. METHODS: This was an experimental study. Slip-lamp photographs of 85 pterygium patients were used to measure the width, extent, and area of pterygia with computer software. Pterygium blood vessels and general ocular redness were quantitatively analyzed with a specific algorithm. The expression of CCR7 and its ligands C-C motif ligand 19 (CCL19) and C-C motif ligand 21 (CCL21) in control conjunctivae and excised pterygia collected during surgery were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and immunofluorescence staining. The phenotype of CCR7-expressing cells was identified by costaining for major histocompatibility complex II (MHC II), CD11b or CD11c. RESULTS: The CCR7 level was significantly increased by 9.6-fold in pterygia compared with control conjunctivae (p = 0.008). The higher the expression of CCR7 was, the more blood vessels appeared in pterygia (r = 0.437, p = 0.002) and the more general ocular redness was (r = 0.51, p < 0.001) in pterygium patients. CCR7 was significantly associated with pterygium extent (r = 0.286, p = 0.048). In addition, we found that CCR7 colocalized with CD11b, CD11c or MHC II in dendritic cells, and immunofluorescence staining showed that CCR7-CCL21 is a potential chemokine axis in pterygium. CONCLUSIONS: This work verified that CCR7 impacts the extent of primary pterygia invading the cornea and inflammation at the ocular surface, which may provide a possibility for a further in-depth understanding of the immunological mechanism in pterygia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- School of Computer Science and Engineering, Sun Yat-sen University, Guangzhou, China.
- Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Electronic address: lingshiqi123@163.com.
Förderung
- Sun Yat-sen University
Zitieren
APA
Wang, T., Peng, R., Ni, H., Zhong, L., Zhang, H., Wang, T., Cheng, H., Bao, T., Jia, X., & Ling, S. (2023). Effects of chemokine receptor CCR7 in the pathophysiology and clinical features of the immuno-inflammatory response in primary pterygium. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110086
Vancouver
Wang T, Peng R, Ni H, Zhong L, Zhang H, Wang T, et al. Effects of chemokine receptor CCR7 in the pathophysiology and clinical features of the immuno-inflammatory response in primary pterygium. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110086
BibTeX
@article{Wang2023,
author = {Wang, Ting and Peng, Ruiping and Ni, Huanqi and Zhong, Lei and Zhang, Huini and Wang, Tao and Cheng, Huanhuan and Bao, Tiancheng and Jia, Xiuhua and Ling, Shiqi},
title = {Effects of chemokine receptor CCR7 in the pathophysiology and clinical features of the immuno-inflammatory response in primary pterygium},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110086}
}
EUVIMED